Onco-Vac Biopharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Onco-Vac Biopharma
Onco-Vac Biopharma Private Limited (OBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2022 (Two years and four months 19 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Mallick, Ashok Vaid, Ram Asrey, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100DL2022PTC404697
-
Company No.
404697
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Sep 2022
-
Date of AGM
03 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Onco-Vac Biopharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Mallick
|
Director | 16-Sep-2022 | Current |
|
Ashok Vaid
|
Director | 16-Sep-2022 | Current |
|
Ram Asrey
|
Director | 10-Feb-2023 | Current |
|
Anant Vishwakarma
|
Director | 14-Nov-2022 | Current |
Financial Performance of Onco-Vac Biopharma.
Enhance accessibility to Onco-Vac Biopharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onco-Vac Biopharma?
Unlock access to Onco-Vac Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Biotech Consortium India LimitedRam Asrey is a mutual person
-
Aureate Healthcare LimitedRaj Mallick is a mutual person
-
Bravo Infotech India Pvt. Ltd.Raj Mallick is a mutual person
-
Pharmamen Logistics Private Limited
Raj Mallick is a mutual person
-
Himanshu Healthcare Private Limited
Raj Mallick is a mutual person
-
Conjuvac (Opc) Private Limited
Ram Asrey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Onco-Vac Biopharma?
Onco-Vac Biopharma has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onco-Vac Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onco-Vac Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.